Page 8 - Key Strategy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 12-Feb-2021 Clinical Trials Market Outlook 2019-2029 | Global Growth Analysis and Forecast Report with Key Players- Clinical Research Partners, Clinical Data Management Providers and Others VALLEY COTTAGE, N.Y. – Collaboration at Its Peak: Key Strategy of Manufacturers in Clinical Trials Market For reducing economic burden, many companies are planning to shift their focus towards on-core business activities, thereby outsourcing their clinical trials activities to the CROs (contract research organizations). This in turn influences biot...

ResearchAndMarkets.com’s offering. Sales for the NASH market to grow from $144.4M in 2019 to $27.2B in 2029 at a Compound Annual Growth Rate (CAGR) of 68.8% across the 7MM. At the end of 2029, the US will contribute around 94.3% of global sales, while the 5EU and Japan will account for around 4.5% and 1.2% of sales, respectively. Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of steatosis (fatty liver), in addition to liver inflammation and damage. Unlike alcoholic liver disease, NASH occurs in those who drink little or ...